Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Researchers identify tumour gene:

This article was originally published in Clinica

Executive Summary

Italian scientists have identified a cancer gene that they say is present in around 74% of tumours. The Trop-2 gene was found to be expressed in the vast majority of cancers, including breast, colon, stomach, lung, prostate, ovary, endometrium, uterine, cervix and pancreas, claimed the researchers, based at the University of Chieti Foundation. In contrast, the gene p53, the most fundamental of tumour suppressors, is indicated in just 50% of tumours, and most other markers can only be detected at high frequency in a subgroup of tumours, said the team. Trop-2 may also play a major role in the spread of cancer. The team's findings were presented at the conference of the European CanCer Organisation (ECCO) in Barcelona, Spain, from 23-27 September.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049844

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel